0001437749-22-014772.txt : 20220610
0001437749-22-014772.hdr.sgml : 20220610
20220610153708
ACCESSION NUMBER: 0001437749-22-014772
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220608
FILED AS OF DATE: 20220610
DATE AS OF CHANGE: 20220610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Fred E
CENTRAL INDEX KEY: 0001339358
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 221008723
MAIL ADDRESS:
STREET 1: 301 COMMERCE STREET
STREET 2: SUITE 3300
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FC 06102022
X0306
4
2022-06-08
0001668243
UroGen Pharma Ltd.
URGN
0001339358
Cohen Fred E
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Stock Option (right to buy)
7.06
2022-06-08
4
A
0
10000
0
A
2032-06-08
Ordinary Shares
10000
10000
D
The shares underlying the stock option will vest in equal quarterly installments over a period of one year.
/s/ Jason Smith, Attorney-in-Fact
2022-06-10